Understanding Early Social Development Eye contact is one of the earliest ways babies connect with their caregivers. From infancy, most babies naturally
Why Early Detection Matters Every child develops at their own pace, but when certain social, communication, or behavioral milestones are missing, it
Every year, thousands of children miss critical windows for early autism intervention—simply because diagnostic tools rely too much on subjective observation.20,31-37 Once that
Key Takeaways For ABA clinics, social media isn’t just a place to post occasional updates—it’s a powerful tool for connecting with families,
Key Takeaways Growing an ABA therapy practice takes more than delivering excellent care—it’s about making sure the families who need you can
Key Takeaways For ABA clinics, the families you want to serve are often searching close to home. Parents want providers within a
Key Takeaways For many ABA clinics, the strongest client connections begin with a trusted recommendation. Parents often turn to people they know—pediatricians,
EarliTec Diagnostics Inc., a digital health company developing novel diagnostic and therapeutic products for children with autism spectrum disorder (ASD) and early
Jamie Pagliaro brings over two decades of leadership in autism and behavioral health to his role as President and CEO of EarliPoint. Most recently, he served as Chief Operating Officer at Rethink, a leading SaaS provider supporting individuals with autism and developmental disabilities. Under his leadership, Rethink’s behavioral health division became the company’s largest business unit, serving thousands of clinicians and driving scalable, tech-enabled care delivery.
Earlier in his career, Jamie was Executive Director of the New York Center for Autism Charter School, the first public charter school in New York State dedicated to children with autism. At EarliPoint, he leads the company’s mission to bring breakthrough science to the front lines of care—empowering providers, families, and health systems with earlier answers and better outcomes.
Dr. Ami Klin is a globally recognized leader in autism research and early detection. As Director of the Marcus Autism Center and Division Chief of Autism and Developmental Disabilities at Emory University School of Medicine, he has dedicated his career to understanding how young children engage with the social world—and how subtle disruptions in attention can signal developmental differences. His pioneering work in eye-tracking science led to the development of EarliPoint™ Evaluation, the first FDA-authorized tool to objectively assess autism in children as young as 16 months.
At EarliPoint, Dr. Klin drives clinical strategy and innovation, ensuring that families and clinicians worldwide have access to timely, science-based insights that enable earlier, more personalized intervention. His career reflects a deep commitment to transforming how society supports children with autism—starting with the earliest signs.